Vandetanib: IQWiG assessed data subsequently submitted by the manufacturer
Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. On the inclusion of additional study data subsequently ...
Oct 1, 2013
0
0